AGIOS PHARMACEUTICALS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at AGIOS PHARMACEUTICALS is $139,050, based on 59 certified filings from FY 2020 to FY 2026. This is 16% higher than the national H-1B median salary of $120,000. Compensation at AGIOS PHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $111,904 and senior positions reaching $185,400 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at AGIOS PHARMACEUTICALS range from $93,288 at the 10th percentile to $185,400 at the 90th percentile, showing a $92,112 spread across experience levels and roles. The 25th percentile is $111,904 and the 75th percentile is $164,424.

Yes, AGIOS PHARMACEUTICALS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 61 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 59 certified applications and a 0% denial rate, AGIOS PHARMACEUTICALS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), AGIOS PHARMACEUTICALS filed 2 H-1B applications, with 2 certified and 0 denied. Over 7 years of data, AGIOS PHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

AGIOS PHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 61 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating AGIOS PHARMACEUTICALS as a potential H-1B sponsor.

This is an excellent approval rate, indicating AGIOS PHARMACEUTICALS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

AGIOS PHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 59 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles AGIOS PHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at AGIOS PHARMACEUTICALS:

The most frequently sponsored role is Research Scientist with 7 filings at a median salary of $113,714. This is followed by Senior Research Scientist (6 filings) and Associate Research Scientist.

AGIOS PHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where AGIOS PHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top AGIOS PHARMACEUTICALS H-1B locations:

The largest H-1B hub for AGIOS PHARMACEUTICALS is Cambridge, MA with 36 filings at a median salary of $132,454. The highest-paying location is Fuquay-Varina, NC at $177,500 median. Salaries range from $111,904 to $177,500 across office locations.

AGIOS PHARMACEUTICALS's median H-1B salary has increased by +45% from FY 2020 ($113,714) to FY 2026 ($164,424). Tracking salary trends over time reveals how AGIOS PHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at AGIOS PHARMACEUTICALS.

Year-by-year breakdown:

• FY 2022: $143,222 (9 certified)
• FY 2023: $140,000 (10 certified)
• FY 2024: $169,744 (9 certified)
• FY 2025: $173,465 (8 certified)
• FY 2026: $164,424 (2 certified)

This 45% growth reflects strong compensation adjustments at AGIOS PHARMACEUTICALS, keeping pace with market demands for H-1B talent.

AGIOS PHARMACEUTICALS primarily files H-1B applications at Wage Level IV, accounting for 49% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making AGIOS PHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 98% of positions at Level II or higher, AGIOS PHARMACEUTICALS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

AGIOS PHARMACEUTICALS's median H-1B salary of $139,050 is 16% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating AGIOS PHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare AGIOS PHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.

AGIOS PHARMACEUTICALS offers above-average H-1B compensation. Combined with their 59 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. AGIOS PHARMACEUTICALS's higher proportion of Level III-IV positions (75%) may benefit from wage-based lottery prioritization.

With 59 certified filings, AGIOS PHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.